General Information of Drug Transporter (DT)
DT ID DTD0356 Transporter Info
Gene Name SLC41A3
Transporter Name Magnesium transporter protein solute carrier family 41 member 3
Gene ID
54946
UniProt ID
Q96GZ6
Epigenetic Regulations of This DT (EGR)

Methylation

  Pancretic ductal adenocarcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in pancretic ductal adenocarcinoma [ 1 ]

Location

5'UTR (cg25742458)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 2.20E-03; Z-score: -2.94E-01

Methylation in Case

9.14E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg24141378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 1.88E-02; Z-score: 4.09E-01

Methylation in Case

8.59E-01 (Median) Methylation in Control 8.52E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in pancretic ductal adenocarcinoma [ 1 ]

Location

Body (cg18949702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 3.04E-02; Z-score: 2.64E-01

Methylation in Case

8.22E-01 (Median) Methylation in Control 8.16E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Bladder cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in bladder cancer [ 2 ]

Location

TSS1500 (cg08509840)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.44E+00 Statistic Test p-value: 1.44E-08; Z-score: 7.16E+00

Methylation in Case

6.97E-01 (Median) Methylation in Control 4.83E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in bladder cancer [ 2 ]

Location

TSS1500 (cg25365006)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 4.17E-02; Z-score: -2.15E+00

Methylation in Case

7.05E-01 (Median) Methylation in Control 7.38E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in bladder cancer [ 2 ]

Location

TSS200 (cg14598764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 2.75E-04; Z-score: 4.65E+00

Methylation in Case

7.93E-01 (Median) Methylation in Control 6.76E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC41A3 in bladder cancer [ 2 ]

Location

TSS200 (cg24663845)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 5.06E-04; Z-score: 3.03E+00

Methylation in Case

7.36E-01 (Median) Methylation in Control 6.33E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in breast cancer [ 3 ]

Location

TSS1500 (cg08509840)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 9.76E-19; Z-score: 3.28E+00

Methylation in Case

6.08E-01 (Median) Methylation in Control 4.58E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in breast cancer [ 3 ]

Location

TSS200 (cg20177385)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 3.39E-10; Z-score: -2.05E+00

Methylation in Case

5.50E-01 (Median) Methylation in Control 6.65E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in breast cancer [ 3 ]

Location

TSS200 (cg14598764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.06E-02; Z-score: -6.59E-01

Methylation in Case

7.23E-01 (Median) Methylation in Control 7.50E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC41A3 in breast cancer [ 3 ]

Location

TSS200 (cg24663845)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 4.05E-02; Z-score: 4.17E-01

Methylation in Case

7.30E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Colorectal cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in colorectal cancer [ 4 ]

Location

TSS1500 (cg23085666)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 9.08E-04; Z-score: -8.44E-01

Methylation in Case

9.52E-01 (Median) Methylation in Control 9.57E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in colorectal cancer [ 4 ]

Location

TSS1500 (cg08509840)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 3.95E-02; Z-score: 4.65E-01

Methylation in Case

8.09E-01 (Median) Methylation in Control 7.74E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in colorectal cancer [ 4 ]

Location

TSS200 (cg20177385)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.14E+00 Statistic Test p-value: 1.38E-10; Z-score: -2.16E+00

Methylation in Case

7.12E-01 (Median) Methylation in Control 8.10E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC41A3 in colorectal cancer [ 4 ]

Location

TSS200 (cg14598764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.22E-03; Z-score: -1.47E+00

Methylation in Case

8.64E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg04539957)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 5.54E-17; Z-score: 2.13E+00

Methylation in Case

7.33E-01 (Median) Methylation in Control 6.17E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg08509840)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 7.03E-04; Z-score: -6.27E-01

Methylation in Case

7.09E-01 (Median) Methylation in Control 7.31E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg23085666)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 7.13E-03; Z-score: -3.32E-01

Methylation in Case

9.44E-01 (Median) Methylation in Control 9.49E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

TSS1500 (cg25365006)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 4.88E-02; Z-score: -2.87E-01

Methylation in Case

7.72E-01 (Median) Methylation in Control 7.79E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

1stExon (cg02318629)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 3.21E+00 Statistic Test p-value: 2.69E-14; Z-score: 6.44E+00

Methylation in Case

3.44E-01 (Median) Methylation in Control 1.07E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

Body (cg03405781)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.17E+00 Statistic Test p-value: 4.58E-11; Z-score: -3.65E+00

Methylation in Case

7.91E-01 (Median) Methylation in Control 9.24E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC41A3 in hepatocellular carcinoma [ 5 ]

Location

Body (cg26446071)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 1.26E-09; Z-score: -2.72E+00

Methylation in Case

6.38E-01 (Median) Methylation in Control 7.37E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in lung adenocarcinoma [ 6 ]

Location

TSS1500 (cg25365006)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 3.35E-02; Z-score: 1.30E+00

Methylation in Case

8.02E-01 (Median) Methylation in Control 7.51E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in lung adenocarcinoma [ 6 ]

Location

TSS1500 (cg23085666)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 4.87E-02; Z-score: -1.32E+00

Methylation in Case

9.26E-01 (Median) Methylation in Control 9.35E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in lung adenocarcinoma [ 6 ]

Location

TSS200 (cg24663845)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.27E-04; Z-score: 2.28E+00

Methylation in Case

7.65E-01 (Median) Methylation in Control 6.34E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC41A3 in lung adenocarcinoma [ 6 ]

Location

TSS200 (cg14598764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 6.21E-03; Z-score: 1.23E+00

Methylation in Case

7.91E-01 (Median) Methylation in Control 7.12E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC41A3 in lung adenocarcinoma [ 6 ]

Location

TSS200 (cg20177385)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 1.33E-02; Z-score: 1.13E+00

Methylation in Case

6.23E-01 (Median) Methylation in Control 5.60E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in papillary thyroid cancer [ 7 ]

Location

TSS1500 (cg08509840)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.20E+00 Statistic Test p-value: 4.54E-14; Z-score: 2.50E+00

Methylation in Case

7.46E-01 (Median) Methylation in Control 6.21E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in papillary thyroid cancer [ 7 ]

Location

TSS200 (cg14598764)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.05E+00 Statistic Test p-value: 7.49E-06; Z-score: 1.29E+00

Methylation in Case

8.05E-01 (Median) Methylation in Control 7.64E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC41A3 in papillary thyroid cancer [ 7 ]

Location

TSS200 (cg24663845)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 1.10E-05; Z-score: 1.36E+00

Methylation in Case

7.41E-01 (Median) Methylation in Control 6.90E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Prostate cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC41A3 in prostate cancer [ 8 ]

Location

TSS1500 (cg04675747)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 4.92E-03; Z-score: 3.66E+00

Methylation in Case

6.67E-01 (Median) Methylation in Control 4.71E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC41A3 in prostate cancer [ 8 ]

Location

TSS1500 (cg14427972)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 2.64E-02; Z-score: 1.66E+00

Methylation in Case

8.61E-01 (Median) Methylation in Control 7.72E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Anaplastic pilocytic astrocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC41A3 in anaplastic pilocytic astrocytoma than that in healthy individual

Studied Phenotype

Anaplastic pilocytic astrocytoma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 2.16E-12; Fold-change: -0.24171686; Z-score: -1.140767182
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Brain neuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC41A3 in brain neuroblastoma than that in healthy individual

Studied Phenotype

Brain neuroblastoma [ICD-11:2A00.11]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.19E-10; Fold-change: -0.282195709; Z-score: -1.189773826
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Brain neuroepithelial tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC41A3 in brain neuroepithelial tumour than that in healthy individual

Studied Phenotype

Brain neuroepithelial tumour [ICD-11:2A00.2Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 4.51E-11; Fold-change: -0.253386305; Z-score: -1.461332918
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Atypical teratoid rhabdoid tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC41A3 in atypical teratoid rhabdoid tumour than that in healthy individual

Studied Phenotype

Atypical teratoid rhabdoid tumour [ICD-11:2A00.1Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 5.67E-08; Fold-change: 0.340177045; Z-score: 1.338520019
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Anaplastic pleomorphic xanthoastrocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC41A3 in anaplastic pleomorphic xanthoastrocytoma than that in healthy individual

Studied Phenotype

Anaplastic pleomorphic xanthoastrocytoma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.45E-06; Fold-change: -0.401097878; Z-score: -1.695329903
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Unclear Phenotype

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-10a directly targets SLC41A3 [ 9 ]

Epigenetic Type

microRNA Experiment Method CLASH

miRNA Stemloop ID

miR-10a miRNA Mature ID miR-10a-5p

miRNA Sequence

UACCCUGUAGAUCCGAAUUUGUG

miRNA Target Type

Direct

Experimental Material

Human embryonic kidney 293 cells (HEK293)
References
1 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
5 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
6 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
7 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
8 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
9 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013 Apr 25;153(3):654-65.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.